Q1 Earnings Forecast for ARDT Issued By Leerink Partnrs

Ardent Health Partners, LLC (NYSE:ARDT) – Leerink Partnrs decreased their Q1 2025 earnings per share estimates for Ardent Health Partners in a report released on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings of $0.20 per share for the quarter, down from their prior forecast of $0.33. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q2 2025 earnings at $0.61 EPS.

Ardent Health Partners (NYSE:ARDT) last released its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.48 billion.

ARDT has been the subject of several other research reports. Royal Bank of Canada lowered their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Tuesday, March 4th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Truist Financial lowered their target price on Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Stephens reiterated an “overweight” rating and issued a $22.00 price target on shares of Ardent Health Partners in a research note on Tuesday. Finally, Morgan Stanley cut their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a research report on Tuesday, January 21st. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, Ardent Health Partners currently has a consensus rating of “Buy” and a consensus price target of $21.18.

Ardent Health Partners Stock Down 0.0 %

Ardent Health Partners stock opened at $12.82 on Friday. The company has a quick ratio of 1.78, a current ratio of 1.91 and a debt-to-equity ratio of 0.78. The stock has a 50-day simple moving average of $14.29 and a 200 day simple moving average of $16.10. Ardent Health Partners has a 12-month low of $12.34 and a 12-month high of $20.72.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the company. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Ardent Health Partners in the fourth quarter worth $27,000. US Bancorp DE bought a new stake in shares of Ardent Health Partners in the 4th quarter worth approximately $31,000. R Squared Ltd bought a new stake in Ardent Health Partners in the fourth quarter worth $37,000. BNP Paribas Financial Markets bought a new stake in shares of Ardent Health Partners in the 3rd quarter valued at about $42,000. Finally, New York State Common Retirement Fund purchased a new stake in shares of Ardent Health Partners during the fourth quarter valued at approximately $48,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.